The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122684524 12268452 4 F 20160321 20160721 20160414 20160729 EXP GB-MYLANLABS-2016M1014514 MYLAN 0.00 Y 0.00000 20160729 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122684524 12268452 1 PS CISPLATIN. CISPLATIN 1 Intravenous (not otherwise specified) 156 MG, UNK U U 91062 156 MG
122684524 12268452 2 SS CISPLATIN. CISPLATIN 1 156 UNK, UNK U U 91062 156 MG
122684524 12268452 3 SS AVASTIN BEVACIZUMAB 1 Intravenous (not otherwise specified) 675 MG, UNK U U 0 675 MG
122684524 12268452 4 SS AVASTIN BEVACIZUMAB 1 Intravenous (not otherwise specified) 675 MG, UNK U U 0 675 MG
122684524 12268452 5 SS DENOSUMAB DENOSUMAB 1 Unknown 120 MG, UNK U U 0 120 MG
122684524 12268452 6 SS NEULASTA PEGFILGRASTIM 1 Subcutaneous 6 MG, UNK U U 0 6 MG
122684524 12268452 7 SS NEULASTA PEGFILGRASTIM 1 Subcutaneous 6 MG, UNK U U 0 6 MG
122684524 12268452 8 SS PEMETREXED PEMETREXED 1 Unknown 1050 MG, UNK U U 0 1050 MG
122684524 12268452 9 SS PEMETREXED PEMETREXED 1 1050 MG, UNK U U 0 1050 MG
122684524 12268452 10 SS APREPITANT. APREPITANT 1 UNK U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122684524 12268452 1 Product used for unknown indication
122684524 12268452 3 Product used for unknown indication
122684524 12268452 5 Product used for unknown indication
122684524 12268452 6 Product used for unknown indication
122684524 12268452 8 Product used for unknown indication
122684524 12268452 10 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
122684524 12268452 OT
122684524 12268452 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
122684524 12268452 Alopecia
122684524 12268452 Contusion
122684524 12268452 Cough
122684524 12268452 Decreased appetite
122684524 12268452 Dehydration
122684524 12268452 Dizziness
122684524 12268452 Dysgeusia
122684524 12268452 Dyspnoea
122684524 12268452 Epistaxis
122684524 12268452 Fall
122684524 12268452 Fatigue
122684524 12268452 Flushing
122684524 12268452 Headache
122684524 12268452 Joint swelling
122684524 12268452 Malaise
122684524 12268452 Melaena
122684524 12268452 Neuropathy peripheral
122684524 12268452 Ocular hyperaemia
122684524 12268452 Paraesthesia
122684524 12268452 Rhinorrhoea
122684524 12268452 Somnolence
122684524 12268452 Syncope

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122684524 12268452 2 20160321 0
122684524 12268452 3 20160321 0
122684524 12268452 6 20160322 0
122684524 12268452 7 20160322 0
122684524 12268452 8 20160321 0
122684524 12268452 9 20160321 0